NetMedi has raised $940,000 seed investment round to expand in Europe sales of its software for collecting and analyzing patient-reported outcomes of cancer care.

netmedi2

The financing round was led by Jaakko Ollila from Metsola Ventures, private investor and founder of MedGroup Kustaa Piha, Harri Tilev from T&T Nordcap, along with significant participation from prior lead investor Reaktor Ventures.

“The team has a profound understanding of the field. Kaiku Health has been designed to enhance the daily clinical routines. The solution provides personalized care for the patients and the clinics are better able to improve their performance,” Kustaa Piha said in a statement.

NetMedi’s Kaiku Health platform, which enables secure online communication between patients and care personnel, is used by 17 clinics in Finland, Sweden and Switzerland.

“We aim to have the best cancer care professionals around the world using and developing Kaiku Health with us. Last year we were able to increase our revenue by 70 percent organically and with the recent funding we are prepared to accelerate up our expansion in Europe this year”, said Lauri Sippola, CEO and Founder of NetMedi.

Kaiku Health is the patient’s individual guide through cancer treatment and recovery, and a real-time dashboard that allows the nurses and doctors to improve outcome-driven care by providing up-to-date patient data.